BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao KL, Wang Y, Shi XH. Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma. World J Gastroenterol 2003; 9(6): 1374-1376 [PMID: 12800260 DOI: 10.3748/wjg.v9.i6.1374]
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1374.htm
Number Citing Articles
1
Riccardo Maurizi Enrici, Mattia F. Osti, Francesca Berardi. Surgery in Multimodal Management of Solid Tumors2009; : 49 doi: 10.1007/978-88-470-1085-7_6
2
Zi-qiang Pan, Xia-yun He, Xiao-mao Guo, Ming Ye, Zhen Zhang, Shao-qin He, Tai-fu Liu. A Phase III Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients With Nasopharyngeal CarcinomaAmerican Journal of Clinical Oncology 2012; 35(6): 600 doi: 10.1097/COC.0b013e31822dfd55
3
A. William Blackstock, Suzanne Russo. Clinical Radiation Oncology2016; : 843 doi: 10.1016/B978-0-323-24098-7.00045-9
4
Dongqing Wang, Jiali Yang, Jingyu Zhu, Baosheng Li, Limin Zhai, Mingping Sun, Heyi Gong, Tao Zhou, Yumei Wei, Wei Huang, Zhongtang Wang, Hongsheng Li, Zicheng Zhang. Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II studyRadiation Oncology 2013; 8(1) doi: 10.1186/1748-717X-8-108
5
Mina Liu, Xuehui Shi, Xiaomao Guo, Weiqiang Yao, Yong Liu, Kuaile Zhao, Guo-Liang Jiang. Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trialRadiation Oncology 2012; 7(1) doi: 10.1186/1748-717X-7-142
6
Hong-Yi Cai, Xiao-Hu Wang, Ying Tian, Li-Ying Gao, Li-Juan Zhang, Zhi-Yan Zhang. Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinomaWorld Journal of Gastroenterology 2008; 14(25): 4082-4086 doi: 10.3748/wjg.14.4082
7
Miaomiao Li, Chengrui Fu, Wei Zhang, Wei Huang, Zhongtang Wang, Tao Zhou, Haiqun Lin, Baosheng Li. Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinomaThe British Journal of Radiology 2016; 89(1060): 20150476 doi: 10.1259/bjr.20150476
8
Su-Ping Sun, Ya-Zhou Liu, Tao Ye, Wen Zhang, Wen-Bin Shen, Jing-Lei Shi, Hai-Ting Xu, Wei-Dong Wang. Randomized clinical trial on seven-day-per-week continuous accelerated irradiation for patients with esophageal carcinoma: Preliminary report on tumor response and acute toxicityWorld Journal of Gastroenterology 2006; 12(43): 7047-7050 doi: 10.3748/wjg.v12.i43.7047
9
A. William Blackstock, Suzanne Russo. Clinical Radiation Oncology2012; : 839 doi: 10.1016/B978-1-4377-1637-5.00043-2
10
Mao‐Bin Meng, Chao Jiang, Li‐Jun Tian, Chun‐Lei Liu, Hong‐Qing Zhuang, Zhong‐Jie Chen, Yong‐Chun Song, Jun Wang, Qing‐Song Pang, Lu‐Jun Zhao, Zhi‐Yong Yuan, Ping Wang. Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinomaThoracic Cancer 2013; 4(2): 174 doi: 10.1111/j.1759-7714.2012.00166.x